3 Rules to Prevent Blood Clots on Road Trips
Planning a long drive? Don't let dangerous blood clots ruin your journey. A leading vascular surgeon shares three simple but crucial rules to keep you safe and healthy during extended road travel.
Planning a long drive? Don't let dangerous blood clots ruin your journey. A leading vascular surgeon shares three simple but crucial rules to keep you safe and healthy during extended road travel.
Discover the groundbreaking FDA-approved medication that reduces cardiovascular risks by tackling chronic inflammation, offering new hope for millions at risk of heart attacks and strokes.
Discover the surprising medical conditions that could be causing your breathlessness during simple walks. Learn when to seek medical attention for this common symptom.
Bengaluru medical experts sound alarm on diabetes drugs being misused for weight loss, highlighting dangerous side effects and long-term health risks.
Eli Lilly is developing Orforglipron oral pills for weight loss and type 2 diabetes that could replace injections, making treatment more accessible and convenient for millions.
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Medical experts in Himachal Pradesh reveal crucial insights about stroke prevention, warning signs, and why immediate action is critical for recovery and avoiding permanent disability.
Medical experts in Ludhiana emphasize FAST recognition and immediate treatment as crucial factors in stroke survival and recovery. Learn how timely intervention can make all the difference.
Acanthosis Nigricans, the dark skin patch on children's necks, is emerging as a visible warning sign of India's growing childhood obesity crisis and early diabetes risk.
Discover six highly effective, doctor-recommended strategies to prevent painful Urinary Tract Infections and maintain optimal urinary health with simple daily habits.
Discover how revolutionary GLP-1 medications including Ozempic, Wegovy, and Mounjaro are transforming America's battle against obesity, offering new hope for sustainable weight loss.
Former Novo Nordisk CEO Lars Fruergaard Jørgensen reveals why revolutionary weight-loss drugs need comprehensive healthcare strategies to tackle obesity effectively. Discover the missing pieces in the fight against this global epidemic.
Discover how community-driven initiatives and everyday compassion are transforming mental health support and saving lives across India through innovative suicide prevention strategies.
India faces a dual health crisis as obesity rates surge alongside undernutrition, creating a massive economic burden that threatens national productivity and healthcare systems.
Discover five practical, expert-backed methods to significantly reduce your risk of heart attacks through simple lifestyle changes and preventive measures you can start today.
Discover how excess weight secretly damages your skin elasticity, causes hair thinning, and triggers premature aging. Expert insights on the surprising connection between weight and beauty.
Groundbreaking research shows popular weight-loss drug semaglutide significantly reduces heart disease risk, offering dual benefits for patients struggling with obesity and cardiovascular health.
Discover the surprising daily routines that are sabotaging your weight loss goals. From sleep patterns to eating speed, learn how to break these obesity-triggering habits.
Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.
In a groundbreaking move, Eli Lilly partners with Cipla to dramatically expand availability of innovative weight loss therapies across India, addressing the growing obesity crisis.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.
New medical research reveals shocking connection between modern lifestyle habits and rising cancer rates among adults under 50. Learn how obesity, sedentary routines, and dietary choices are creating a health crisis.
Indian pharmaceutical leader Biocon Biologics partners with Civica to disrupt US insulin market with affordable alternatives, while also eyeing anti-obesity therapy opportunities.
Groundbreaking research reveals a disturbing surge in obesity-related cancers affecting Indians across all age groups. Learn which cancers show the strongest connection and what experts recommend for prevention.
Discover how incorporating regular walking into your daily routine can shield you from eight major health conditions, from diabetes to heart disease.
Meta expands safety toolkit with age-specific protections, educational resources, and scam reporting features to safeguard older Indians on Facebook, Instagram, and WhatsApp.
Mizoram combines football passion with social cause as Aizawl hosts innovative drug awareness match featuring local clubs and police teams to combat substance abuse among youth.
Discover why some obese individuals remain metabolically healthy while others develop serious conditions. Learn about fat distribution, lifestyle factors, and prevention strategies from medical experts.
Discover why being thin doesn't mean you're healthy. Learn about 'skinny fat' - the silent threat increasing heart disease risk among Indians with normal BMI.